Remission in cancer is often experienced as a long-awaited, life-changing relief. But for a subset of patients, remission doesn’t imply total eradication. Tiny numbers of cancer cells sometimes break away from the primary tumour, travel to distant organs, and enter a sleep-like state called dormancy. New research published in Nature (2025) shows that common respiratory infections notably influenza and SARS-CoV-2 can trigger inflammation that wakes these dormant cells in the lungs and rapidly converts them into growing metastases. The study combines experiments in mouse models with organoid work and large human health-record analyses, and points to inflammation (especially the cytokine IL-6) as a key molecular switch.

This isn’t a door slammed shut on survivorship; it’s a clarifying, mechanistic insight. Knowing how a relapse can be provoked opens rational pathways for prevention: vaccines, prompt antiviral treatment, and possibly targeted ways to blunt inflammatory signals during infections. Below I unpack the evidence, explain the biology in plain terms, and explore what this might mean clinically and for public health.

Dormant Cancer Cells: Sleeping Seeds In The Body

When people hear the phrase “in remission,” the natural assumption is that the cancer is gone. In reality, cancer cells can be stealthy travelers. As a primary tumour grows, a few cells often break away, slip into the bloodstream, and migrate to distant tissues such as the lungs, bones, or liver. Once there, they don’t necessarily grow into new tumours right away. Instead, they can press a kind of biological pause button.

These quiet passengers are called disseminated cancer cells (DCCs). They can remain dormant for years or even decades. They are so few and so metabolically silent that even sensitive scans or blood tests can’t reliably detect them. They’re also highly resistant to chemotherapy and radiation, which mostly target rapidly dividing cells. Dormant cells can therefore outlast treatment and lurk unseen within the body.

Scientists often compare them to embers in an abandoned campfire. Left alone, they pose no immediate danger. But if the conditions shift if a gust of wind fans the embers the fire can reignite. The question that has puzzled oncology researchers for decades is: what provides that gust of wind?

What The Researchers Actually Did

The new study approached this question using multiple complementary lines of evidence.

Mouse models of breast cancer
Mice genetically engineered to develop mammary tumours were found to harbor only a handful of dormant cancer cells in their lungs. The researchers infected some of these mice with influenza A (H1N1) or SARS-CoV-2. The results were striking: within days, the dormant cells awoke and began dividing. Within two weeks, visible metastatic lesions were present. In some experiments, the number of carcinoma cells in the lungs increased by 100-fold. By contrast, uninfected mice showed no such changes.

Mechanistic insights
Tissue and genetic analyses revealed that interleukin-6 (IL-6) a protein messenger produced during inflammation was a major driver of this process. IL-6 acts like a chemical alarm bell during infection, summoning immune cells and helping the body mount defenses. But in this context, IL-6 inadvertently shook dormant cancer cells awake. Mice engineered to lack IL-6, or those treated with IL-6 blockers, showed much less reactivation of cancer cells during infection.

Human population data
Of course, findings in mice are not enough. To see if the same pattern held true in people, researchers turned to massive health databases. Using the UK Biobank, which tracks over half a million participants, they found that cancer survivors who tested positive for COVID-19 were nearly twice as likely to die of cancer in the year following infection compared to matched survivors who remained COVID-negative. A similar analysis of a U.S. database of tens of thousands of breast-cancer patients found that those with a COVID-19 infection had about a 40–50% higher risk of developing lung metastases compared with those who avoided the virus.

How Viral Infections “Wake” Dormant Cells

Dormant cancer cells are held in check by a delicate balance between the body’s immune surveillance and the tissue environment. Viral infections disturb that balance in at least three ways:

1. Cytokine surge – During infection, immune cells unleash a storm of chemical messengers. IL-6 is especially important: normally protective, it can double as a growth stimulant. To dormant cells, IL-6 is like a trumpet blast urging them to march.
2. Immune distraction – Fighting a virus absorbs immune resources. Killer T cells that normally police and destroy rogue cancer cells are often suppressed or redirected by helper T cells during infection. Dormant cells may seize the opportunity to expand while the immune army is preoccupied.
3. Tissue remodeling – Inflammation triggers tissue repair, including growth factors and changes in the extracellular matrix. This remodeled environment can be more permissive to cancer-cell proliferation and migration.

The metaphor of the embers works beautifully here: a campfire smolders silently until a sudden gust of wind in this case, inflammation fans the embers into flames.

Human Evidence: Messy But Persuasive

Observational studies in humans are always vulnerable to confounding factors. Pandemic-era survivors faced delayed care, socioeconomic stresses, and uneven access to testing. These variables complicate interpretation. Yet the fact that the timing, magnitude, and direction of human findings align so closely with the controlled animal experiments makes it hard to dismiss the link.

The strongest effects appeared in the first year after infection, hinting that there may be a window of particular vulnerability. After that, the risk seemed to subside, though not completely. This fits the ember metaphor: once a gust of wind blows, some embers catch fire immediately, some burn out, and others may smolder for longer.

Clinical And Public-Health Implications

This research doesn’t mean cancer survivors should panic every time they catch a cold. But it does add weight to preventive strategies already recommended for public health.

Vaccination
Flu shots and COVID-19 vaccines reduce the severity of infections. Less severe illness means lower inflammatory storms, which could reduce the likelihood of dormant cells being jolted awake. Vaccines, in this light, are not just protection from acute infection but potential guardians of remission.

Early antiviral treatment
Drugs like Tamiflu (for influenza) and Paxlovid (for COVID-19) were designed to shorten illness and reduce complications. But by blunting viral replication and inflammation, they might also reduce the metastatic risk. Clinical trials will be needed to test this possibility directly.

COVID and the flu can trigger dormant cancer cells in your lungs: study https://t.co/CPVRPXX5hI pic.twitter.com/jN1CfHtFwa

— New York Post (@nypost) September 3, 2025

Targeted therapies
IL-6 inhibitors are already in use for autoimmune conditions and for severe COVID-19. Could they be deployed in cancer survivors during respiratory infections to prevent dormant-cell awakening? The mouse evidence suggests yes, but in practice this approach is complicated. Suppressing IL-6 too much could impair the body’s ability to fight the virus itself.

Lifestyle and personal vigilance
For survivors, simple precautions matter. Masking during flu season, good hand hygiene, rest, balanced nutrition, and stress management all strengthen immune resilience. Survivorship care may increasingly include guidance on infection prevention and rapid response.

The Big Questions Still Unanswered

Like all major discoveries, this one opens more doors than it closes. Among the urgent questions:

• Do other cancers behave the same way, or is this effect specific to breast cancer and lung metastases?
• How long does the heightened risk persist after a respiratory infection? Weeks? Months? Longer?
• Are repeated mild infections cumulatively risky, or is it primarily severe infections that drive the effect?
• How protective are vaccines in real-world conditions against this risk? The assumption is that they help but by how much?
• Could prophylactic immunotherapies be used strategically for high-risk survivors during infection seasons?

Answering these will require large, prospective studies and close collaboration between oncologists, immunologists, and infectious-disease researchers.

Spiritual And Philosophical Reflections

Science can sometimes feel stark, but discoveries like this also invite a more holistic reflection. Dormancy itself is a profound metaphor. Just as hidden cancer cells rest quietly in the body, many aspects of human experience old traumas, dormant talents, unrealized dreams lie quiescent within us. Sometimes external forces awaken them, for better or worse.

The research reminds us that remission is not an erasure of the past but an equilibrium with it. In medicine, vigilance means protecting that balance through vaccines, therapies, and preventive care. In life, vigilance means tending the conditions that keep our “embers” from reigniting destructively while also cultivating those dormant seeds that we do wish to awaken: creativity, resilience, compassion.

This duality the embers of disease versus the embers of growth underscores the strangeness and beauty of biology. The same molecules that heal can also harm. The same silence that protects can also threaten. Health, like life, is dynamic balance.

From Uncertainty To Strategy

The revelation that respiratory viruses can reawaken dormant cancer cells reframes remission. It is not a permanent finish line but a negotiated peace, vulnerable to disruption. That sounds unsettling, yet it also empowers: understanding the mechanism transforms mystery into strategy.

Cancer survivors and their clinicians can use this knowledge to act wisely: staying current with vaccines, taking respiratory symptoms seriously, seeking prompt care, and discussing infection-prevention strategies as part of survivorship care. Researchers can pursue targeted interventions like IL-6 modulation with renewed clarity.

Respiratory viruses are here to stay. But with awareness, prevention, and continued science, survivors need not live in fear of every infection. The embers of disease may never vanish entirely, but they can be kept cold and in their place, the embers of life, creativity, and resilience can burn brightly instead.

Loading...